Journal
NEOPLASIA
Volume 2, Issue 6, Pages 505-513Publisher
NATURE AMERICA INC
DOI: 10.1038/sj.neo.7900120
Keywords
aspirin; apoptosis; cytochrome c; mitochondria; NSAID
Categories
Funding
- NCI NIH HHS [P01 CA069381, CA69381] Funding Source: Medline
- NIAID NIH HHS [R01 AI040646, AI40646] Funding Source: Medline
Ask authors/readers for more resources
Nonsteroidal anti-inflammatory drugs (NSAID) reduce the risk for cancer, due to their antiproliferative and apoptosis-inducing effects. A critical pathway for apoptosis Involves the release of cytochrome c from mitochondria, which then interacts with Apaf-1 to activate caspase proteases that orchestrate cell death, In this study we found that treatment of a human cancer cell line with aspirin induced caspase activation and the apoptotic cell morphology, which was blocked by the caspase inhibitor zVAD-fmk. Further analysis of the mechanism underlying this apoptotic event showed that aspirin induces translocation of Bax to the mitochondria and triggers release of cytochrome c into the cytosol. The release of cytochrome c from mitochondria was inhibited by overexpression of the antiapoptotic protein Bcl-2 and cells that lack Apaf-1 were resistant to aspirin-induced apoptosis, These data provide evidence that the release of cytochrome c is an important part of the apoptotic mechanism of aspirin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available